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Abstract. 
 
Skeletal muscle in vertebrates is derived 
from somites, epithelial structures of the paraxial meso-
derm, yet many unrelated reports describe the occa-
sional appearance of myogenic cells from tissues of 
nonsomite origin, suggesting either transdifferentiation 
or the persistence of a multipotent progenitor. Here, we 
show that clonable skeletal myogenic cells are present 
in the embryonic dorsal aorta of mouse embryos. This 
finding is based on a detailed clonal analysis of different 
tissue anlagen at various developmental stages. In vitro, 
these myogenic cells show the same morphology as sat-
ellite cells derived from adult skeletal muscle, and ex-
press a number of myogenic and endothelial markers. 
Surprisingly, the latter are also expressed by adult satel-
lite cells. Furthermore, it is possible to clone myogenic 
cells from limbs of mutant c-Met
 
2
 
/
 
2
 
 embryos, which 
lack appendicular muscles, but have a normal vascular 
system. Upon transplantation, aorta-derived myogenic 
cells participate in postnatal muscle growth and regen-
eration, and fuse with resident satellite cells.
The potential of the vascular system to generate skel-
etal muscle cells may explain observations of non-
somite skeletal myogenesis and raises the possibility 
that a subset of satellite cells may derive from the vas-
cular system.
Key words: myogenesis • satellite cells • endothelial 
cells • multipotent progenitors • vascular–endothelial 
cadherin
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T
 
 is generally accepted that all skeletal muscle cells of
the vertebrate body derive from the dorsal domain of
somites, epithelial structures that form in a cranio–
caudal sequence from the paraxial mesoderm, flanking the
axial neural tube on both sides (Christ and Ordhal, 1995).
This evidence largely derives from classic chick–quail
transplantation experiments, and has been confirmed by in
vitro explant culture in both birds and mammals (reviewed
in Cossu et al., 1996a).
Skeletal myogenesis begins soon after onset of somito-
genesis and continues throughout development and post-
natal growth. Adult muscle retains proliferative potential
due to the presence of quiescent satellite cells. Cells in the
somites are first instructed to become myogenic by signals
emanating from neighboring tissues, such as notochord,
neural tube, and dorsal ectoderm (Cossu et al., 1996a).
Once committed, a subset of dorsal epithelial somite cells
will begin migrating beneath the dermomyotome to form
the myotome, the first skeletal muscle structure, initially
composed of terminally differentiated postmitotic, mono-
nucleate cells (Denetclaw et al., 1997; Kahane et al., 1998).
Cells of the dermomyotome, exposed to the same signals,
enter other mesodermal lineages, such as dermis or endo-
thelium, or remain undifferentiated as progenitors of suc-
cessive generations of myogenic cells that will later give
rise to primary and secondary fibers, as well as to satellite
cells.
Most experiments addressing the origin of skeletal mus-
cle have analyzed only the embryonic stages of develop-
ment. It has been assumed that skeletal muscle cells that
form during fetal and postnatal life share the same origin,
although experimental proof for this is lacking.
However, much evidence has accumulated for in vivo or
in vitro myogenic differentiation of cells of nonsomite ori-
gin during late fetal and postnatal development (reviewed
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in Cossu, 1997), when satellite cells are considered to be
the only remaining myogenic progenitors (Bischoff, 1994).
Whether or not satellite cells originate exclusively from
somites also remains an open question.
We recently reported that some myogenic cells that par-
ticipate in skeletal muscle regeneration originate in the
bone marrow and are delivered to the muscle through the
blood circulation (Ferrari et al., 1998). This prompted us
to define the embryological origin of these myogenic cells,
as well as of satellite cells, but lack of specific markers has
hampered this work. Lineage studies for skeletal muscle
are also complicated by the multinucleate nature of the
differentiated tissue. However, it is possible to clone mam-
malian satellite cells that, in the mouse, show a typical
round-shaped morphology during proliferation, clearly
different from spindle-shaped myoblasts (Cossu et al.,
1987). Upon serum withdrawal, these cells will elongate
and then fuse into multinucleate contracting myotubes.
By extending this clonal analysis to various early embry-
onic structures, we now report that the highest yield in
myogenic clones with a morphology typical of satellite
cells and expressing a number of myogenic and endothe-
lial markers was obtained from dorsal aorta, a tissue not
previously known to give rise to skeletal myogenic cells.
These results have implications for current interpretations
of fetal and postnatal myogenesis.
 
Materials and Methods
 
Transgenic Mouse Lines 
 
Experiments were performed on MLC3F-nlacZ, Myf-5-nlacZ, c-Met dou-
ble tyrosine mutant, and Splotch mouse lines (Kelly et al., 1995; Maina et
al., 1996; Tajbakhsh et al., 1996, 1997).
 
Cell and Organ Cultures 
 
Embryos were dissected and embryonic structures were isolated as de-
scribed (Cossu et al., 1996b). The tissues were then either separated into a
single cell suspension by gentle pipetting or cultured as explants (Cusella-
De Angelis et al., 1994) for periods ranging from 3–7 d. At the end of the
culture period, tissues were either stained for 
 
b
 
-galactosidase activity, im-
munofluorescence, or used for reverse transcriptase (RT)
 
1
 
 -PCR. Cultures
were grown as described (Cossu et al., 1996b). Northern Blot analysis and
RT-PCR were performed as described (Ferrari et al., 1997). Oligos for
 
Pax3
 
 amplification were 5
 
9
 
-TGT GGA ATA GAC GTG GGC TGG TA-
3
 
9
 
 and 5
 
9
 
-AGG AGG CGG ATC TAG AAA GGA AG-3
 
9
 
; for 
 
MyoD
 
: 5
 
9
 
-
CAC TAC AGT GGC GAC TCA GAC GCG-3
 
9
 
, nt 730–753, 5
 
9
 
-CCT
GGA CTC GCG CAC CGC CTC ACT-3
 
9
 
, nt 873–850.
 
Immunocytochemistry 
 
The antibodies used against MyoD, myosin heavy chains, and c-Met have
been described (Bader et al., 1982; Tajbakhsh et al., 1994; Koishi et al.,
1995; Maina et al., 1996). The antibodies against M-cadherin and MNF
were donated by A. Starzyski-Powitz (Humangenetik fur Biologen,
Goethe-Universitat, Frankfurt, Germany) and R. Bussel-Duby (Univer-
sity of Texas SW Medical Center, Dallas, TX), respectively (Irintchev et
al., 1994; Garry et al., 1997). The antibodies against vascular-endothelial
(VE) -cadherin, CD34, and PECAM were donated by E. Dejana and C.
Gherlanda (Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy).
Antibodies against VEGR2, 
 
a
 
M-integrin (MAC-1), 
 
b
 
3-integrin, and von
Willebrand (Santa Cruz and Pharmingen) were donated by A. Stoppac-
ciaro (Dipartimento di Medicinal Sperimentale e Patologia, Universita
‘La Sapienza,’ Rome, Italy). Immunocytochemistry on tissue sections and
cultured cells was carried out as described (Tajbakhsh et al., 1994).
 
Transplantation Studies 
 
Genetically labeled cells were injected into the regenerating Tibialis ante-
rior (TA) of 
 
SCID/bg
 
 mice as described (Ferrari et al., 1998). Fetal limbs
were isolated from E16–17 wild-type (wt) embryos and, after removal of
the skin, were transplanted subcutaneously into newborn (P1–2) MLC3F-
nlacZ mice (Lagrand et al., 1997). Alternatively, freshly dissected dorsal
aortas from E9 MLC3F-nlacZ embryos were transplanted into the TA of
newborn (P4–5) 
 
SCID/bg
 
 mice. At different periods after transplantation,
the mice were killed, the transplanted and the contralateral TA muscles or
the transplanted fetal limb were recovered, and stained for 
 
b
 
-galactosi-
dase activity or cryostat-sectioned and processed for immunofluorescence.
 
Results
 
Clonal Analysis of Myogenic Cells
 
Mouse satellite cells grown in culture under clonal condi-
tions appear as round-shaped cells expressing myogenic
markers, such as 
 
MyoD
 
, 
 
desmin
 
, and 
 
c-Met
 
, and differenti-
ate into multinucleated myotubes upon mitogen depriva-
tion. Satellite cells can be cloned from skeletal muscle of
postnatal mice and of fetuses older than E15, but not from
earlier stages (Cossu et al., 1987). We found that when
limbs from E13 or E11, or even forelimbs from E9.5 (20–
24 somites) embryos were precultured as explants for
three, five, or seven days, respectively, and then succes-
sively dissociated to a single cell suspension and cultured
at low density, myogenic clones with the phenotype of sat-
ellite cells appeared (one example is shown in Fig. 2 A).
Thus, cells competent to generate satellite cell-like clones
must enter the limb field as early as the first migratory
population of somite-derived myoblasts, but seem not to
acquire this competence until later developmental stages
and upon maintenance of interaction with other limb cells.
 
Myogenic Clones Are Derived from Dorsal Aorta 
 
We set out to investigate, by the explant preculture
method described above, the possible presence of satellite
cell-like cells in different tissue anlagen of the mouse em-
bryo. We cultured newly formed somites or segmental
plates, neural tube, dorsal ectoderm, lateral mesoderm,
dorsal aorta (from the corresponding body level), and
heart. Careful digestion with pancreatin-trypsin allowed
clean dissection of the epithelial somites from both the
neural tube/notochord complex axial and lateral meso-
derm (Fig. 1, top). Possible contamination not detected by
microscopy was ruled out by RT-PCR analysis, which did
not reveal expression of the medial markers 
 
Pax3
 
 and
 
MyoD
 
 in the dorsal aorta or in other lateral structures
(Fig. 1, bottom, and data not shown). After one week, half
of the explants were stained for the expression of myosin
heavy chains and, as expected, only cultures from somites,
limb buds, and heart contained hundreds of positive cells.
Virtually no myosin positive cells were present in cultures
from other tissues (not shown). The rest of these explants
were dissociated to single cell suspensions and cloned by
limited dilution under conditions that favor clonal growth
of satellite cells. Fig. 2 A shows the typical morphology of
a satellite cell-like clone derived from precultured E9.5
forelimb bud explants, indistinguishable from a clone di-
rectly derived from older limbs (not shown). Unexpect-
edly, the vast majority of clones with this morphology
came from explants of dorsal aorta (Fig. 2 C). In contrast,
 
1. 
 
Abbreviations used in this paper:
 
 
 
b
 
-gal
 
1
 
, 
 
b
 
-galactosidase positive;
Met
 
D
 
, Met receptor unable to transduce the HGF signal; RT, reverse tran-
scriptase; TA, Tibialis anterior; VE, vascular–endothelial; wt, wild-type. 
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most clones derived from precultured somites had a fibro-
blast-like morphology (Fig. 2 B). After shifting the clonal
cultures to differentiation medium, all round-shaped satel-
lite cell-like, but not the fibroblast-like, clones differenti-
ated into myosin positive cells (Fig. 2 D).
Quantitative analysis showed that a high proportion of
satellite cell-like clones (defined by morphology and myo-
sin expression) were derived from explants of dorsal aorta
(Fig. 3 A). These precultured explants gave rise to an aver-
age of five times more clones than the somites, whereas
the latter contained ten times more cells for the same seg-
ment length. Thus, each segment of dorsal aorta can give
rise to 50 satellite cell-like clones on a per cell basis, versus
one clone originating from somites. Very few clones of sat-
ellite cell-like cells originated from lateral mesoderm and
neural tube, and none from ectoderm and heart.
As reported above, many satellite cell-like clones were
obtained from cultures of forelimb bud from 20–24 somite
embryos. At these stages the limb bud already contains
both myoblasts and vascular endothelial cells. Thus, all the
tissues that gave rise to satellite cell-like clones contain en-
dothelial cells. The only tissue that, despite the presence of
abundant endothelium (endocardium), never gave rise to
satellite cell-like clones was heart. This may reflect unique
tissue interactions that occur during endocardium specifi-
cation (Sugi and Markwald, 1996) and may result in a
more restricted developmental potential, as compared
with noncardiac endothelium.
We next investigated whether the aorta would maintain
the potential of generating clones of satellite cell-like cells
during later developmental stages. Fig. 3 B shows that this
potential declines during development, but at E17 is still
approximately one third of the maximal value obtained at
E9.5. Postnatal or adult aorta, as well as smaller vessels
dissected from limb muscle, did not give rise to satellite
cell-like clones, either directly or after explant culture (not
shown). Forelimbs from the same stage were used as posi-
tive controls.
 
Endothelial Markers Are Expressed in Myogenic Cells 
from Aorta and in Satellite Cells
 
These novel results led us to compare the phenotype of
these clonable satellite cell-like cells with that of adult sat-
ellite cells and fetal myoblasts. Table I and Fig. 4 show that
most known myogenic markers (
 
MyoD
 
, 
 
Myf-5
 
, 
 
desmin
 
,
 
MNF
 
, 
 
c-Met
 
, and 
 
M-cadherin
 
) were expressed by clones of
dorsal aorta, as well as by postnatal muscle satellite cells
and fetal myoblasts. Unexpectedly, vascular-endothelial
markers, such as 
 
VE-cadherin
 
, 
 
VEGF-R2
 
, 
 
a
 
M-integrin
 
, 
 
b
 
3
integrin
 
, 
 
P-selectin
 
, smooth 
 
a
 
-actin
 
, and 
 
PECAM
 
 were also
expressed by the first two cell types, while fetal myoblasts
did not express 
 
VE-cadherin
 
, 
 
P-selectin
 
 and 
 
b
 
3 integrin
 
 (all
clones were negative for von Willebrand factor). Fig. 5
shows clones of aorta-derived myogenic cells (Fig. 5 A)
and of adult satellite cells (Fig. 5 B) that all coexpress 
 
VE-
cadherin
 
 on the surface and 
 
MyoD
 
 in the nucleus. Clones
from dorsal aorta also expressed 
 
CD34
 
, but only during
Figure 1. Top, Morphology of embryonic structures isolated
from E9.5 mouse embryos after pancreatin digestion. Bottom,
RT-PCR revealed the medial markers MyoD and Pax3 were ex-
pressed in dissected somites (different ratio of Pax3 to MyoD in
different lanes depends upon isolation of somites at different
cranio–caudal level); Pax3, but not MyoD, in the neural tube;
and none of the markers was detectable in dissected dorsal aorta. Figure 2. Morphology of typical clones derived from explant cul-
tures of E9.5 limb bud (A), somites (B), and dorsal aorta (C), cul-
tured in growth medium. Immunofluorescence analysis with anti-
sarcomeric myosin antibody of a clone from dorsal aorta, after
three days of culture in differentiation medium is shown in D.
Bar, 15 mm.
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the first two days in vitro. Muscle fibroblasts (used as con-
trols) were negative for all of these markers. Thus, clones
from the dorsal aorta were indistinguishable from clones
of satellite cells in terms of differential expression of any
of 15 different markers analyzed. Expression of 
 
VE-cad-
herin
 
 was confirmed by Northern blot analysis in satellite
cells (Fig. 6). It was unexpected, and is notable that satel-
lite cells derived from adult muscle express a number of
endothelial markers.
 
Myogenic Clones Can Be Derived from the Limb Buds 
of c-Met Null Embryos
 
In embryos null for 
 
c-Met
 
, or expressing a Met receptor
unable to transduce the HGF signal (Met
 
D
 
), myoblasts fail
to emigrate from the somite and to colonize the limb bud
(Bladt et al., 1995; Maina et al., 1996). Although devoid of
myogenic cells, the developing limbs of these mutants
have normal blood vessels, as shown in Fig. 7, A and B.
Forelimb buds from Met
 
D
 
 homozygous embryos were cul-
tured and then dissociated into single cell suspensions and
grown as clones. Satellite cell-like clones emerged from
forelimbs of homozygous Met
 
D
 
 embryos (
 
z
 
50% of those
obtained from heterozygous or wt siblings). This demon-
strates the presence of clonogenic satellite cell-like cells
that are not derived from somitic myoblasts. The clones
obtained from mutant embryos were notably smaller (av-
eraging 4 to 6 cells) than those derived from the heterozy-
gous siblings (averaging 20 to 60 cells), and expressed high
levels of 
 
MyoD
 
 (Fig. 7, F and G). With time in culture,
some of these clones disappeared and occasionally frag-
mented chromatin was observed, but the surviving clones
differentiated into myosin-positive mono- or binucleate
muscle cells.
We thus conclude that at least a fraction of satellite cell-
like myogenic progenitors are present in the limbs of Met
 
D
 
mutant embryos, which are colonized by endothelial cells,
but not by somite-derived myoblasts. Their growth is im-
paired, likely because they cannot respond to SF/HGF,
and eventually apoptosis may occur. Still, they represent a
considerable fraction (
 
z
 
50%) of those obtained from wt
embryos. Similar results were also obtained using limb
buds of Splotch embryos as a source of myogenic cells (not
shown). Splotch mice are defective in the 
 
Pax-3
 
 gene and
their phenotype overlaps with the 
 
Met
 
 null in terms of lack
of migration of somite-derived precursors in the limbs
(Bober et al., 1994; Goulding et al., 1994).
 
In Vivo Myogenic Potential of Cells from Dorsal Aorta
 
We tested the potential of transplanted aorta-derived sat-
ellite cell-like cells to participate in in vivo perinatal
growth and regeneration of skeletal muscle, in three dif-
ferent sets of experiments.
In the first experiment, a cell suspension from cultured
Figure 3. A, Quantitative analysis of satellite cell-like clones
(shown in Fig. 1) from explant cultures of different anlagen of
E9.5 embryos. Each bar is the average of at least three separate
experiments, each performed in triplicate. B, Time course of the
appearance of satellite cell-like clones from explants of vessels
(___) or limb buds (- - -) at successive periods of development. The
time course of the appearance of satellite cell-like clones, directly
cloned from limb buds in vivo is also shown (– ? –).
 
Table I. Expression of Different Markers by Aorta-derived and 
Other Mesodermal Cells
 
Cell type: Aorta Satellite Fetal myoblast Fibroblast
 
MyoD
 
1 1 1 2
 
Myf-5
 
6 6 6 2
 
Desmin
 
1 1 1 2
 
Smooth 
 
a
 
-actin
 
1 1 1 2
 
MNF
 
1 1 1 2
 
c-Met
 
1 1 1 2
 
M-Cad
 
1 1 1 2
 
VE-Cad
 
1 1 2 2
 
VEGF-R2
 
1 1 1 2
 
P-Selectin (CD62P)
 
1 1 2 2
 
a
 
M-Integrin (CD11b)
 
1 1 2
 
/
 
1 2
 
b
 
3-Integrin (CD61)
 
1 1 2 2
 
PECAM (CD31)
 
2
 
/
 
1 2
 
/
 
1 2
 
/
 
1 2
 
von Willebrand
 
2 2
 
ND
 
2
 
CD34
 
1
 
/
 
2 1
 
/
 
2 2 2
 
Aorta-cells were cloned from seven day-old organ cultures of dorsal aorta from E9.5
day embryos. Immunofluorescence was carried out on at least ten individual clones of
each cell type in three separate cultures. Satellite cells were cloned from hind limb skel-
etal muscles of P10 mice. Fetal myoblasts and fibroblasts were cultured as described
(Cossu et al., 1987). Myoblasts were identified by coexpression of 
 
MyoD
 
 or 
 
desmin
 
.
 
1
 
, Indicates that 
 
.
 
95% of the cells in the clone expressed a high level of the antigen
(examples shown in Fig. 3) during the phase of clonal growth. 
 
6
 
, Indicates that 
 
z
 
10–
20% of the cells in most clones expressed 
 
Myf-5
 
, revealed by 
 
b
 
-galactosidase staining
of clones derived from 
 
Myf-5
 
/nLacZ embryos. 
 
2
 
/
 
1
 
, Indicates that virtually all the
cells of a clone expressed high levels of the antigen only after fusion. 
 
1
 
/2, Indicates
expression of the antigen only during the first days of clonal growth.
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explants of E9.5 embryonic aorta of MLC3F-nLacZ trans-
genic mice, in which transgene expression is restricted to
heart and skeletal muscle (Kelly et al., 1995), was mixed
with a tenfold excess of satellite cells from wt P10 mice.
Part of this suspension was grown in culture. Fig. 8 A
shows a myotube containing one b-galactosidase positive
(b-gal1) nucleus which, because of the genetic label, must
be derived from the dorsal aorta explant. The rest of the
mixed cell suspension was injected into a regenerating TA
muscle of SCID/bg mice, where they gave rise to small
clusters of several b-gal1 nuclei within regenerating fi-
bers, surrounded by a laminin-positive basal membrane
(Fig. 8, B and C). Thus, cells derived from the dorsal aorta
can fuse with satellite cells in vitro and participate in skele-
tal muscle regeneration in vivo. All these results show that
myogenic cells derived from the aorta cannot be distin-
guished from bona fide satellite cells.
For the second experiment, to test whether myogenic
cells derived from the vasculature may also contribute to
normal development of skeletal muscle, we transplanted
E16 fetal limbs from wt embryos under the skin of a new-
born (P2) MLC3F-nLacZ transgenic mouse (Lagrand et al.,
1997). After one week, the transplanted limbs had grown
and were vascularized by the host. Whole-mount staining
revealed the presence of many b-gal1 nuclei clustered in
the area where the vessels had penetrated the transplant
(Fig. 9 A). Sections of the same samples revealed b-gal1
nuclei within myosin-positive fibers adjacent to VE-cad-
herin–positive vessels (Fig. 9, B–D).
In the third experiment, isolated dorsal aortas from E9
MLC3F-nLacZ transgenic embryos were transplanted into
the TA on one side of newborn (P 4–5) SCID/bg mice. Af-
ter two weeks, the TA anterior contained a cluster of fi-
Figure 4. Myogenic and endothelial markers are expressed in
aorta-derived myogenic cells and in satellite cells. Immunofluo-
rescence analysis with antibodies against MyoD (A and B), c-Met
(C and D), Desmin (E and F), VE-cadherin (G and H), and b-3
integrin (I and J) of clones derived from E9.5 dorsal aorta (A, C,
E, G, and I) or P10 satellite cells (B, D, F, H, and J). Bar, 10 mm.
Figure 5. MyoD and VE-cadherin are coexpressed in aorta-
derived myogenic cells and in satellite cells. Double immunoflu-
orescence analysis with antibodies against MyoD (red) and
VE-cadherin (green) of clones derived from E9.5 dorsal aorta
(A) and of adult satellite cells (B). Bar, 10 mm.
Figure 6. The message for
VE-cadherin is expressed in
adult satellite cells. Northern
blot analysis of VE-cadherin
expression in E 9.5 embry-
onic hearts (H), adult satellite
cells (CS), and primary fibro-
blasts (fb).
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bers with many b-gal1 nuclei in the area of the transplant
(Fig. 10 A). However, the untreated contralateral TA
was also found to contain many b-gal1 nuclei dispersed
throughout the whole muscle (Fig. 10 B), indicating that
these cells had reached the developing fibers through the
circulation. In contrast, when somites from the same em-
bryos were similarly transplanted into the developing TA
muscle of newborn immune-deficient mice, many b-gal1
nuclei were observed surrounding a core of cartilage (pre-
Figure 7. Myogenic clones are present in the limbs of c-Met–defi-
cient embryos. Phase-contrast microscopy of wt (A) and MetD
(B) E14 embryos showing normal vasculature in mutant embryos
(arrow). b-galactosidase staining of wt (C) and MetD (D) crossed
to MLC3F-nLacZ embryos showing complete absence of muscle
(b-gal1) cells in the limb of E15 mutant embryos. Immunofluo-
rescence analysis with antibodies against MyoD of clones derived
from E13 limb buds of wt (E) or MetD (F and G) embryos. Nu-
clear staining (Hoechst) is shown in H, J, and K. Bar, 10 mm.
Figure 8. Aorta-derived myogenic cells undergo myogenesis in
vitro and in vivo. A, Cocultures of clones from E9.5 dorsal aorta
from MLC3F-nLacZ embryos and P10 wt satellite cells. Arrows
indicate one b-gal1 and one b-gal2 nucleus within the same myo-
tube. Bar, 10 mm. B, Cross-section of a regenerating TA of a
SCID/bg injected with pooled clones of satellite cell-like clones,
showing a cluster of b-gal1 nuclei (arrow) within small regener-
ating fibers, labeled with an antibody against laminin in C. Bar,
25 mm.
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sumably from the sclerotome), but no b-gal1 nuclei were
found in other muscles (data not shown).
Discussion
Skeletal Myogenic Cells from the
Embryonic Vasculature
Our data show that cells derived from embryonic vessels
can give rise to skeletal myogenic cells. There is no skele-
tal muscle surrounding the developing vessels in the
mouse embryo. In vertebrates, somitic muscles derive
from dorsal mesoderm, whereas the intraembryonic vascu-
lature mainly derives from ventral splancnic mesoderm
(Flamme and Risau, 1992), although the dorsal portion of
the aorta is derived from the paraxial mesoderm and is not
endowed with hemopoietic capacity (Pardanaud et al.,
1996).
In explant cultures, we found that dorsal aorta did not
contain differentiated muscle cells, which typically appear
in similar cultures of somitic or limb tissues. However,
when dorsal aortas were first explant-cultured for a week,
and then dissociated to single cell suspensions and cloned
under conditions that favor expansion of adult satellite
cells, many myogenic clones appeared, undistinguishable
from bona fide satellite cells. The fact that such clones
could not be obtained directly from the aorta suggests a
requirement for growth factors provided by neighboring
cells during the incubation as organ culture, and absent in
our culture medium.
The myogenic clones express all the early myogenic
markers considered, including M-cadherin, MNF, and
desmin. Virtually 100% of these cells express MyoD, while
only a minority of them express Myf-5. Although the ma-
jority of postnatal satellite cells, upon clonal expansion in
vitro or activation in vivo, express both MyoD and Myf5
(Cornelison and Wold, 1997; Cooper et al., 1999), in the
MyoD knockout mouse regeneration is impaired via an ef-
fect on the satellite cell population (Megeney et al., 1996).
The unexpected coexpression of a number of endothe-
lial and myogenic markers in cells derived from the dorsal
aorta suggests that these myogenic cells may be derived
from true endothelial cells or from a common precursor. It
is interesting to note that endothelial cells appear to be the
only cell type capable of generating immortal clones in
early postimplantation mouse embryos (Hatzopoulos et al.,
1998) and that circulating endothelial progenitor cells can
be isolated from adult human blood (Asahara et al., 1997).
These endothelial progenitors typically express CD34.
Aorta-derived myogenic clones only express CD34 at the
beginning of clonal expansion, suggesting early loss of this
antigen upon entry in the myogenic pathway. Other endo-
thelial markers, such as VE-cadherin, are lost upon ter-
minal differentiation, but are coexpressed with MyoD
throughout clonal expansion.
To our surprise, endothelial markers were also coex-
pressed with MyoD in bona fide satellite cells, a puzzling
observation for cells presumed to be of somitic origin. The
problem of the embryonic origin of satellite cells has never
been directly approached, except in a study that was in-
conclusive due to technical difficulties in identifying quail
nuclei in chick–quail chimeras at the ultrastructural level
Figure 9. Host-derived myogenic cells are present in fetal limbs
transplanted under the skin of newborn MLC3F-nLacZ trans-
genic mice and vascularized by the host. A, Whole-mount stain
reveals a cluster of b-gal1 nuclei in the transplanted limb. B–D,
Cross-section of the same sample stained for b-galactosidase ac-
tivity revealed the b-gal1 nuclei (B) inside myosin positive mus-
cle fibers (D) adjacent to VE-cadherin positive vessels (C). Bar,
25 mm.
Figure 10. Aorta-derived myogenic cells contribute to growing
fibers and also circulate. A, Whole-mount stain reveals clusters
of b-gal1 nuclei (arrow) in the TA of P14 SCID/bg mice, two
weeks after transplantation of embryonic aortas from E9
MLC3F-nLacZ embryos. B, Whole-mount stain of the contralat-
eral TA of the same SCID/bg reveals several b-gal1 nuclei (ar-
row) dispersed throughout the whole muscle. Bar, 50 mm.
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(Armand et al., 1983). It is interesting to note that, unlike
postnatal satellite cells, fetal myoblasts were found not to
express VE-cadherin, b3-integrin, or P-selectin, in keeping
with the possibility that several phenotypically distinct
populations of myogenic cells may appear sequentially
during muscle histogenesis (Cossu and Molinaro, 1987).
Our data suggest that, differently from embryonic and
fetal myoblasts derived from somites, satellite cells may
derive, at least in part, from progenitors in the dorsal
aorta. Coexpression of endothelial and myogenic markers
supports this hypothesis. In normal development, endo-
thelial cells first migrate into the limb bud from the lateral
edge of newly formed somites and are soon followed by
myogenic cells (Solursh et al., 1987). In contrast, only en-
dothelial cells (but not myogenic precursors) enter the
limb bud of embryos mutant for c-Met or Pax3. The em-
bryos do not survive until the stage when satellite cells ap-
pear in vivo. However, explant cultures from limb buds of
these embryos yielded a significant number of satellite
cell-like clones (z50% of wt), supporting the idea that
they are the progeny of endothelial cells, rather than myo-
blasts. Interestingly, all the cells of these clones express
MyoD, do not grow to more than four to eight cells, and,
for the most part, eventually die, but the few surviving un-
dergo terminal muscle differentiation. Met signaling in re-
sponse to SF/HGF thus appears to be required for the
clonal growth of these newly identified myogenic cells.
Myogenic Progenitors from the Dorsal Aorta 
Contribute to Postnatal Muscle Growth
and Regeneration
Expression of myogenic markers in vitro suggests a poten-
tial for in vivo myogenic differentiation. Our results indi-
cate that these myogenic cells do participate in both post-
natal muscle growth and regeneration. When directly
injected into the regenerating TA of an immune-deficient
mouse, genetically labeled nuclei of cells from the dorsal
aorta are incorporated into newly formed muscle fibers,
much as bona fide satellite cells. Indeed, skin fibroblasts
also are incorporated into regenerating fibers when simi-
larly injected, although at an extremely low frequency
(Gibson et al., 1995). Thus, while regenerating muscle
must be a rich source of signals recruiting competent cells
to myogenesis, it is also possible that within a population
of skin fibroblasts, there may be a small fraction of still
multipotent progenitors (Bianco and Cossu, 1999) and it is
only this fraction that is capable of differentiating in vivo.
When a fetal limb is transplanted under the skin of a
transgenic MLC3F-nlacZ newborn mouse, it is vascular-
ized by the host. These limbs contain b-gal1 nuclei, usu-
ally clustered in the area of the vessel in-growth, suggest-
ing that they were associated with it, rather than deriving
from neighboring host muscle. Finally, when an embryonic
dorsal aorta is transplanted into the growing TA of a new-
born immune-deficient mouse, it gives rise to many b-gal1
nuclei clustered in the area of the transplant. This does not
happen if the aorta is grown in vitro, indicating that signals
from the surrounding developing skeletal muscle recruit
some of the aorta cells (endothelium and/or pericytes) to
myogenesis. Remarkably, several dispersed b-gal1 nuclei
are also present in the contralateral untreated TA, indicat-
ing that these myogenic cells must have reached this site
through the circulation, much as happens for the adult
progenitors in bone marrow (Ferrari et al., 1998). Possible
contamination from adjacent somitic tissue is ruled out be-
cause when somites are similarly transplanted, they give
rise to differentiated muscle cells only in the area of trans-
plant.
Transdifferentiation or Multipotentiality?
Our data may simply represent one example of transdif-
ferentiation leading to the formation of skeletal muscle
cells, as reported for the esophagus (Patapoutian et al.,
1995), the neural tube (Tajbakhsh et al., 1994), the kidney
(Mayer and Leinwand, 1997), or mesenchymal cells from
bone marrow (Grigoriadis et al., 1988) and dermis (Salva-
tori et al., 1995). We propose a different explanation: that,
at least in this case and in the case of mesenchymal cells,
multipotent progenitors may be present in the endothe-
lium (or closely associated cells). When invading develop-
ing muscle anlagen, these progenitors will be subject to a
muscle field, and thus will adopt a satellite cell fate. When
the vessels develop inside a different tissue, these cells
may adopt the specific fate of that tissue, and contribute to
its histogenesis. The only tissue in which these progenitors
remain demonstrable may be the bone marrow, and this
would explain our recent observation that cells from the
bone marrow can contribute new myogenic cells to re-
generating skeletal muscle (Ferrari et al., 1998). Multipo-
tent mesenchymal cells, capable of producing osteoblasts,
chondroblasts, adipocytes, and even skeletal muscle, have
long been known to be present in the bone marrow (Caplan,
1991; Prockop, 1997). We do not know whether the cells
we describe in embryonic vessels represent the progeni-
tors of multipotent mesenchymal cells or a separate lin-
eage with at least part of the same developmental poten-
tial. Preliminary observations suggest that clones of dorsal
aorta can give rise to osteoblast-like cells in the presence
of BMP-2. Indeed, multipotentiality is preserved, even in
adult muscle satellite cells, as shown by the fact that BMP2
can switch them to an osteogenic fate (Katagiri et al.,
1994).
In vivo work will clarify whether the contribution of
aorta-derived myogenic cells is quantitatively relevant
during fetal and/or postnatal growth and regeneration of
skeletal muscle.
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